| mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-08 |
| mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-08 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
| mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.2 |
6e-07 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.24 |
3e-06 |
| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
4e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |